Serum NOX1 and Raftlin as New Potential Biomarkers of Interest in Schizophrenia: A Preliminary Study.
Onur HurşitoğluErgul Belge KurutaşRebecca StrawbridgeOmer Faruk UygurEmrah YildizThomas J ReillyPublished in: Neuropsychiatric disease and treatment (2022)
This preliminary study indicating elevations in serum NOX1 and raftlin levels in patients with SCZ supports the importance of OS and inflammatory processes in the etiopathogenesis of the illness.